NL-OMON34670已完成不适用
An Open Label Study to Determine ADME of [14C] labeled SLV334 and its Metabolites after Single Intravenous Dose Infusion. - SLV334 ADME study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Healthy male
- •- 18-55 years of age, inclusive
- •- BMI 18.0 - 28.0 kg/m2 (weight between 50 and 100 kg inclusive)
- •- non-smoker
排除标准
- •Suffering from: hepatitis B, cancer or HIV/AIDS. In case of participation in another drug study within 90 days before the start of this study or being a blood donor within 60 days from the start of the study. In case of donating more than 1.5 liters of blood in the 10 months prior the start of this study.
研究者
相似试验
已完成
不适用
An Open-Label Study to Determine the ADME of 14C-labeled SLV337 after a Single Dose of an Oral SuspensioType 2 diabetes mellitus10018424diabetesNL-OMON34267aboratoires Fournier S.A.12
已完成
1 期
14-C ADME (Absorption, Disposition, Metabolism and Excretion) Study in ManHealthy SubjectsNCT01176201Abbott Products12
已完成
1 期
Study to Investigate ADME of 14C Labeled SLV334 After an i.v. InfusionPharmacology, ClinicalNCT01044524Solvay Pharmaceuticals6
已完成
1 期
A Study of Carbon-14-Labelled [14C] LY3372689 in Healthy Male ParticipantsHealthyNCT05749848Eli Lilly and Company8
已完成
1 期
An Open-label Trial to Evaluate Mass Balance of Tavapadon at Steady State in Healthy SubjectsHealthy SubjectsNCT04241393Cerevel Therapeutics, LLC12